Dana Aftab, Ph.D.

Executive Vice President, Business Operations

Dana Aftab, Ph.D. has served as Executive Vice President, Business Operations since February 2016 and has been at Exelixis for almost 18 years. He began his tenure with Exelixis in the company's drug discovery group, where he led the pharmacology department and served as Project Team Leader for discovery programs in oncology and metabolic diseases. In 2007, Dr. Aftab moved into the clinical development organization where he implemented a broad translational medicine platform at the company. Before joining Exelixis, Dr. Aftab held senior scientist positions at Versicor and Metaxen. He received his Ph.D. from Yale, did postdoctoral work at UC Berkeley in the field of oncogene signaling, and completed his undergraduate degree at UC Santa Barbara.